| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.03 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.18 | 0.03 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.03 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |